Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 70452

470 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
November 14, 2014
Product types
Drug
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Attix Pharmaceuticals

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

470 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 470

5-Aminolevulinic Acid Hydrochloride active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-491-2015
Recall number
D-491-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
510 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 2 of 470

4-Aminopyridine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-492-2015
Recall number
D-492-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1310 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 3 of 470

2-Deoxy-D-Glucose active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, On

D-493-2015
Recall number
D-493-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
3100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 4 of 470

3,4-Diaminopyridine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-494-2015
Recall number
D-494-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
375 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 5 of 470

2,3-Dimercaptopropanesulfonic Acid Sodium Salt (DMPS) active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-495-2015
Recall number
D-495-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1480 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 6 of 470

2,3-Dimercaptosuccinic Acid (DMSA) active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-496-2015
Recall number
D-496-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
9625 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 7 of 470

5-Fluorouracil active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-497-2015
Recall number
D-497-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 8 of 470

2-Methoxyestradiol active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-498-2015
Recall number
D-498-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
90 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 9 of 470

Acetazolamide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-499-2015
Recall number
D-499-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
2100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 10 of 470

Acetylsalicyclic acid active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-500-2015
Recall number
D-500-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 11 of 470

Acyclovir Sodium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-501-2015
Recall number
D-501-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 12 of 470

Adapalene active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-502-2015
Recall number
D-502-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
25 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 13 of 470

Adenosine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-503-2015
Recall number
D-503-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 14 of 470

Albendazole active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-504-2015
Recall number
D-504-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
10065 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 15 of 470

Albumin (Bovine) active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-505-2015
Recall number
D-505-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
500 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 16 of 470

Albuterol Sulfate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-506-2015
Recall number
D-506-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1890 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 17 of 470

Aldosterone active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-507-2015
Recall number
D-507-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
16 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 18 of 470

Alpha Chymotrypsin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-508-2015
Recall number
D-508-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 19 of 470

Amantadine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-509-2015
Recall number
D-509-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
23000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 20 of 470

Ambroxol HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-510-2015
Recall number
D-510-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
2000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 21 of 470

Amikacin Sulfate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-511-2015
Recall number
D-511-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
7500 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 22 of 470

Amiloride HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-512-2015
Recall number
D-512-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
25 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 23 of 470

Aminocaproic Acid active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-513-2015
Recall number
D-513-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
100000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 24 of 470

Aminophylline active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-514-2015
Recall number
D-514-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
11600 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 25 of 470

Aminopyridine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-515-2015
Recall number
D-515-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
2000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 26 of 470

Amitriptyline HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-516-2015
Recall number
D-516-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
6050 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 27 of 470

Amlodipine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-517-2015
Recall number
D-517-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 28 of 470

Amlodipine besylate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-518-2015
Recall number
D-518-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
5200 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 29 of 470

Ammonium Tetrathiomolybdate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-519-2015
Recall number
D-519-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
200 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 30 of 470

Amoxicillin Trihydrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-520-2015
Recall number
D-520-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
100 grams

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
Stability Data Does Not Support Expiry

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Stability Data Does Not Support Expiry: All lots of all products repackaged and distributed between 01/05/12 through 02/12/15 are being recalled because they were repackaged without data to support the printed expiry date.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 31 of 470

Amphotericin B active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-521-2015
Recall number
D-521-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
5500 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 32 of 470

Anastrozole active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-522-2015
Recall number
D-522-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
615 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 33 of 470

Aprepitant active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-523-2015
Recall number
D-523-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
50 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 34 of 470

Artemether active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-524-2015
Recall number
D-524-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 35 of 470

Artesunate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-525-2015
Recall number
D-525-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1800 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 36 of 470

Atazanavir active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-526-2015
Recall number
D-526-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
50 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 37 of 470

Atomoxetine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-527-2015
Recall number
D-527-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
200 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 38 of 470

Atovaquone active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-528-2015
Recall number
D-528-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
3080 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 39 of 470

Atropine Sulfate Monohydrate USP active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-529-2015
Recall number
D-529-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
7305 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 40 of 470

Avanafil active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-530-2015
Recall number
D-530-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 41 of 470

Azatadine Maleate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-531-2015
Recall number
D-531-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
50 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 42 of 470

Azelastine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-532-2015
Recall number
D-532-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
300 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 43 of 470

Azithromycin Dihydrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-533-2015
Recall number
D-533-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
30316 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 44 of 470

Baclofen active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-534-2015
Recall number
D-534-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
134535 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 45 of 470

Belladonna Extract Powder active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-535-2015
Recall number
D-535-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
7800 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 46 of 470

Benazepril active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-536-2015
Recall number
D-536-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
5 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 47 of 470

Benazepril HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-537-2015
Recall number
D-537-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
3999 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 48 of 470

Benoxinate HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-538-2015
Recall number
D-538-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
50 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 49 of 470

Benztropine Mesylate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-539-2015
Recall number
D-539-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 50 of 470

Betahistine Dihydrochloride active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-540-2015
Recall number
D-540-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
2000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 51 of 470

Betamethasone Sodium Phosphate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-541-2015
Recall number
D-541-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
75 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 52 of 470

Bethanechol Chloride active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-542-2015
Recall number
D-542-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
250 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 53 of 470

Bimatoprost active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-543-2015
Recall number
D-543-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
17 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 54 of 470

Bisacodyl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-544-2015
Recall number
D-544-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
50 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 55 of 470

Bismuth Subcarbonate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-545-2015
Recall number
D-545-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
25000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 56 of 470

Bovine Insulin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-546-2015
Recall number
D-546-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
10 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 57 of 470

Bromfenac Sodium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-547-2015
Recall number
D-547-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
70 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 58 of 470

Bromhexine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-548-2015
Recall number
D-548-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
3000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 59 of 470

Bromocriptine Mesylate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-549-2015
Recall number
D-549-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
35 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 60 of 470

Budesonide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-550-2015
Recall number
D-550-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
3270 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 61 of 470

Bupivacaine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-551-2015
Recall number
D-551-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
14100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 62 of 470

Bupivacaine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-552-2015
Recall number
D-552-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
24503 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 63 of 470

Bupropion HCI active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-553-2015
Recall number
D-553-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
14080 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 64 of 470

Cabergoline active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-554-2015
Recall number
D-554-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
15 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 65 of 470

Calcipotriene active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-555-2015
Recall number
D-555-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
3 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 66 of 470

Calcitriol active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-556-2015
Recall number
D-556-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 67 of 470

Calcium Sulfate Hemihydrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-557-2015
Recall number
D-557-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
2000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 68 of 470

Cantharidin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-558-2015
Recall number
D-558-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
46 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 69 of 470

Capecitabine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-559-2015
Recall number
D-559-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
75 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 70 of 470

Carbazochrome active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-560-2015
Recall number
D-560-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
744 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 71 of 470

Carbimazole active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-561-2015
Recall number
D-561-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
2090 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 72 of 470

Carboplatin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-562-2015
Recall number
D-562-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
25 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged between 01/05/12 through 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 73 of 470

Carboxymethyl Cellulose Sodium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-563-2015
Recall number
D-563-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
7000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 74 of 470

Carboxymethyl Dextran active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-564-2015
Recall number
D-564-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 75 of 470

Carvedilol active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-565-2015
Recall number
D-565-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 76 of 470

Cefadroxil Monohydrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-566-2015
Recall number
D-566-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
9000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 77 of 470

Cefazolin Sodium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-567-2015
Recall number
D-567-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
50 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 78 of 470

Cefixime active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-568-2015
Recall number
D-568-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
2000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 79 of 470

Cefpodoxime Proxetil active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-569-2015
Recall number
D-569-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
2000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 80 of 470

Celecoxib active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-570-2015
Recall number
D-570-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
2900 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 81 of 470

Cephalexin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-571-2015
Recall number
D-571-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
8000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 82 of 470

Cephalexin Monohydrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-572-2015
Recall number
D-572-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
2000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 83 of 470

Cetirizine HCI active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-573-2015
Recall number
D-573-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
3200 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 84 of 470

Chlorambucil active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-574-2015
Recall number
D-574-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
4350 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 85 of 470

Chloramphenicol active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-575-2015
Recall number
D-575-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
174510 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 86 of 470

Chloramphenicol Palmitate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-576-2015
Recall number
D-576-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
17000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 87 of 470

Chlorobutanol Anhydrous pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-577-2015
Recall number
D-577-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
13600 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 88 of 470

Chlorobutanol Hemihydrate pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-578-2015
Recall number
D-578-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
6900 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 89 of 470

Chloroquine Phosphate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-579-2015
Recall number
D-579-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
10000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 90 of 470

Chloroxine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-580-2015
Recall number
D-580-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
300 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 91 of 470

Chlorpromazine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-581-2015
Recall number
D-581-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
30 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 92 of 470

Cholestyramine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-582-2015
Recall number
D-582-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
7750 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 93 of 470

Cidofovir Anhydrous active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-583-2015
Recall number
D-583-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
420 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 94 of 470

Cidofovir Dihydrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-584-2015
Recall number
D-584-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
540.75 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 95 of 470

Cilostazol active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-585-2015
Recall number
D-585-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 96 of 470

Cimetidine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-586-2015
Recall number
D-586-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 97 of 470

Cinacalcet HCI active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-587-2015
Recall number
D-587-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
25 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 98 of 470

Ciprofloxacin HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-588-2015
Recall number
D-588-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
3100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 99 of 470

Cisatracurium Besylate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-589-2015
Recall number
D-589-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1110 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 100 of 470

Cisplatin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-590-2015
Recall number
D-590-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
34 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 101 of 470

Citalopram Hydrobromide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-591-2015
Recall number
D-591-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged between 01/05/12 through 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 102 of 470

Clarithromycin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-592-2015
Recall number
D-592-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
2500 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 103 of 470

Clindamycin HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-593-2015
Recall number
D-593-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1220 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 104 of 470

Clomiphene Citrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-594-2015
Recall number
D-594-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1550 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 105 of 470

Clomipramine HCI active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-595-2015
Recall number
D-595-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
87144 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 106 of 470

Clonidine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-596-2015
Recall number
D-596-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
525 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 107 of 470

Clopidogrel Bisulfate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-597-2015
Recall number
D-597-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
4745 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 108 of 470

Clozapine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-598-2015
Recall number
D-598-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
500 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 109 of 470

Colchicine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-599-2015
Recall number
D-599-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
124 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 110 of 470

Cortisone Acetate Micronized active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-600-2015
Recall number
D-600-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 111 of 470

Croscarmellose Sodium pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-601-2015
Recall number
D-601-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
7000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 112 of 470

Crospovidone pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-602-2015
Recall number
D-602-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
10500 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 113 of 470

Crotamiton active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-603-2015
Recall number
D-603-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 114 of 470

Cyanocobalamin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-604-2015
Recall number
D-604-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
8489 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 115 of 470

Cyclobenzaprine HCI active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-605-2015
Recall number
D-605-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
69860 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 116 of 470

Cyclophosphamide Monohydrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-606-2015
Recall number
D-606-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
22610 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 117 of 470

Cyclosporine A active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-607-2015
Recall number
D-607-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
42756 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 118 of 470

D-Cycloserine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-608-2015
Recall number
D-608-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
50 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 119 of 470

Dacarbazine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-609-2015
Recall number
D-609-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
50 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 120 of 470

Dantrolene Sodium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-610-2015
Recall number
D-610-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
8447 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 121 of 470

Dantrolene Sodium (Light Yellow) active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-611-2015
Recall number
D-611-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
3005 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 122 of 470

Dantrolene Sodium (Orange) active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-612-2015
Recall number
D-612-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1005 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 123 of 470

Dapiprazole HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-613-2015
Recall number
D-613-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
500 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 124 of 470

Dapsone active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-614-2015
Recall number
D-614-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
5420 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 125 of 470

Daptomycin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-615-2015
Recall number
D-615-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
10 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 126 of 470

Darunavir active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-616-2015
Recall number
D-616-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
110 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 127 of 470

Dasatinib active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-617-2015
Recall number
D-617-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 128 of 470

Demecarium Bromide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-618-2015
Recall number
D-618-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
629 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 129 of 470

Demeclocycline HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-619-2015
Recall number
D-619-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged between 01/05/12 through 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 130 of 470

Desmopressin Acetate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-620-2015
Recall number
D-620-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
2 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 131 of 470

Desonide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-621-2015
Recall number
D-621-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
50 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 132 of 470

Desoximetasone active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-622-2015
Recall number
D-622-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
50 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 133 of 470

Dexamethasone Base active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-623-2015
Recall number
D-623-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
5010 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 134 of 470

Dexamethasone Sodium Phosphate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-624-2015
Recall number
D-624-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1700 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 135 of 470

Dexchlorpheniramine Maleate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-625-2015
Recall number
D-625-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 136 of 470

Dexmedetomidine HCI active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-626-2015
Recall number
D-626-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
130 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 137 of 470

Dexrazoxane active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-627-2015
Recall number
D-627-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
195 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 138 of 470

Dextran-70 active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-628-2015
Recall number
D-628-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 139 of 470

Diclofenac Sodium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-629-2015
Recall number
D-629-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
118940 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 140 of 470

Digoxin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-630-2015
Recall number
D-630-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
36 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 141 of 470

Dimethyl Fumarate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-631-2015
Recall number
D-631-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
2000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 142 of 470

Diphemanil Methylsulfate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-632-2015
Recall number
D-632-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
200 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 143 of 470

Diphenylcyclopropenone active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-633-2015
Recall number
D-633-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 144 of 470

Disulfiram active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-634-2015
Recall number
D-634-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
48010 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 145 of 470

Dobutamine Hydrochloride active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-635-2015
Recall number
D-635-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
4997 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 146 of 470

Docetaxel Anhydrous active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-636-2015
Recall number
D-636-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
10 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 147 of 470

Domperidone active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-637-2015
Recall number
D-637-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
96560 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 148 of 470

Dopamine HCI active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-638-2015
Recall number
D-638-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1150 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 149 of 470

Doxapram HCI Monohydrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-639-2015
Recall number
D-639-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1853 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 150 of 470

Doxorubicin HCI active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-640-2015
Recall number
D-640-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
5 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 151 of 470

Doxycycline HCI active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-641-2015
Recall number
D-641-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
38900 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 152 of 470

Doxycycline Hyclate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-642-2015
Recall number
D-642-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
335420 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 153 of 470

Doxycycline Monohydrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-643-2015
Recall number
D-643-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
12000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 154 of 470

D-Penicillamine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-644-2015
Recall number
D-644-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 155 of 470

Droperidol active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-645-2015
Recall number
D-645-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 156 of 470

Duloxetine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-646-2015
Recall number
D-646-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
10 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 157 of 470

EDTA Dipotassium Magnesium Salt Dihydrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-647-2015
Recall number
D-647-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
300 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 158 of 470

Enalapril Maleate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-648-2015
Recall number
D-648-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 159 of 470

Enzalutamide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-649-2015
Recall number
D-649-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
11 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 160 of 470

Epinephrine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-650-2015
Recall number
D-650-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
50 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 161 of 470

Esomeprazole Magnesium Trihydrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-651-2015
Recall number
D-651-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 162 of 470

Estradiol active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-652-2015
Recall number
D-652-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
4031 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 163 of 470

Estradiol (Micronized) active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-653-2015
Recall number
D-653-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
2762 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 164 of 470

Estradiol (Non-Micronized) active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-654-2015
Recall number
D-654-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
500 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 165 of 470

Estradiol Cypionate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-655-2015
Recall number
D-655-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
3925 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 166 of 470

Estriol active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-656-2015
Recall number
D-656-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
8045 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 167 of 470

Estriol (Ultra-Micronized) active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-657-2015
Recall number
D-657-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
38769 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 168 of 470

Estrone active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-658-2015
Recall number
D-658-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
5 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 169 of 470

Etamsylate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-659-2015
Recall number
D-659-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
77400 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 170 of 470

Ethambutol HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-660-2015
Recall number
D-660-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
57500 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 171 of 470

Ethinyl Estradiol active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-661-2015
Recall number
D-661-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
146 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 172 of 470

Ethopropazine HCI active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-662-2015
Recall number
D-662-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
2000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 173 of 470

Etidronate Disodium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-663-2015
Recall number
D-663-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1850 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 174 of 470

Etodolac active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-664-2015
Recall number
D-664-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
2500 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 175 of 470

Etomidate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-665-2015
Recall number
D-665-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
830 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 176 of 470

Etoposide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-666-2015
Recall number
D-666-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 177 of 470

Etravirine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-667-2015
Recall number
D-667-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
20 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 178 of 470

Everolimus active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-668-2015
Recall number
D-668-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1 gram

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 179 of 470

Exemestane active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-669-2015
Recall number
D-669-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
965 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 180 of 470

Ezetimibe active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-670-2015
Recall number
D-670-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 181 of 470

Famciclovir active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-671-2015
Recall number
D-671-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
27302 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 182 of 470

Famotidine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-672-2015
Recall number
D-672-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
4716 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 183 of 470

Felbamate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-673-2015
Recall number
D-673-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
7000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 184 of 470

Finasteride active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-674-2015
Recall number
D-674-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
907 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 185 of 470

Flibanserin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-675-2015
Recall number
D-675-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 186 of 470

Floxuridine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-676-2015
Recall number
D-676-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
2350

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 187 of 470

Fluconazole active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-677-2015
Recall number
D-677-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 188 of 470

Flucytosine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-678-2015
Recall number
D-678-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 189 of 470

Flumazenil active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-679-2015
Recall number
D-679-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
594 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 190 of 470

Flumethasone active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-680-2015
Recall number
D-680-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
805 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 191 of 470

Flunarizine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-681-2015
Recall number
D-681-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
10 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 192 of 470

Fluorescein Sodium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-682-2015
Recall number
D-682-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
10000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 193 of 470

Fluorexon active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-683-2015
Recall number
D-683-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 194 of 470

Fluoxetine Hydrochloride active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-684-2015
Recall number
D-684-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
8750 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 195 of 470

Fluphenazine Decanoate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-685-2015
Recall number
D-685-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 196 of 470

Fluphenazine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-686-2015
Recall number
D-686-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 197 of 470

Fluprostenol active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-687-2015
Recall number
D-687-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 198 of 470

Flurbiprofen active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-688-2015
Recall number
D-688-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
60000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 199 of 470

Flutamide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-689-2015
Recall number
D-689-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
20 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 200 of 470

Fluticasone Propionate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-690-2015
Recall number
D-690-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
16770 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 201 of 470

Formestane active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-691-2015
Recall number
D-691-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 202 of 470

Formoterol Fumarate Dihydrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-692-2015
Recall number
D-692-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
2 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 203 of 470

Fulvestrant active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-693-2015
Recall number
D-693-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1 gram

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 204 of 470

Furazolidine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-694-2015
Recall number
D-694-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 205 of 470

Furosemide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-695-2015
Recall number
D-695-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
4500 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 206 of 470

Gabapentin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-696-2015
Recall number
D-696-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
365402 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 207 of 470

Gatifloxacin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-697-2015
Recall number
D-697-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 208 of 470

Gefitinib active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-698-2015
Recall number
D-698-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 209 of 470

Gemfibrozil active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-699-2015
Recall number
D-699-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
5000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 210 of 470

Glipizide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-700-2015
Recall number
D-700-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
500 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 211 of 470

Guanabenz Acetate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-701-2015
Recall number
D-701-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
2461 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 212 of 470

Halobetasol Propionate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-702-2015
Recall number
D-702-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 213 of 470

Heparin Sodium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-703-2015
Recall number
D-703-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
3062 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 214 of 470

Heptaminol Hydrochloride active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-704-2015
Recall number
D-704-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 215 of 470

Histamine Diphosphate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-705-2015
Recall number
D-705-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 216 of 470

Histamine Phosphate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-706-2015
Recall number
D-706-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
5 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 217 of 470

Homatropine Methylbromide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-707-2015
Recall number
D-707-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
940 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 218 of 470

Hyaluronic Acid Sodium Salt (Injection Grade) active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-708-2015
Recall number
D-708-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1685 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 219 of 470

Hyaluronic Acid Sodium Salt (Ophthalmic Grade) active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-709-2015
Recall number
D-709-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
52 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 220 of 470

Hyaluronic Acid Sodium Salt (Pharma Grade) active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-710-2015
Recall number
D-710-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
16315 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 221 of 470

Hydralazine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-711-2015
Recall number
D-711-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
500 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 222 of 470

Hydrochlorothiazide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-712-2015
Recall number
D-712-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
5500 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 223 of 470

Hydrocortisone active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-713-2015
Recall number
D-713-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 224 of 470

Hydrocortisone base active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-714-2015
Recall number
D-714-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
5 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 225 of 470

Hydrocortisone Micronized active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-715-2015
Recall number
D-715-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
300 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 226 of 470

Hydrocortisone Sodium Succinate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-716-2015
Recall number
D-716-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
6100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 227 of 470

Hydroxocobalamin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-717-2015
Recall number
D-717-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1145 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 228 of 470

Hydroxocobalamin Acetate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-718-2015
Recall number
D-718-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
5 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 229 of 470

Hydroxocobalamin Base active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-719-2015
Recall number
D-719-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1010 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 230 of 470

Hydroxocobalamin HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-720-2015
Recall number
D-720-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
673 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 231 of 470

Hydroxyprogesterone Caproate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-721-2015
Recall number
D-721-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
5500 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 232 of 470

Hydroxypropyl Beta Cyclodextrin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-722-2015
Recall number
D-722-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1200 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 233 of 470

Hydroxyurea active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-723-2015
Recall number
D-723-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
4250 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 234 of 470

Hydroxyzine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-724-2015
Recall number
D-724-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
75000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 235 of 470

Hyoscine Butylbromide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-725-2015
Recall number
D-725-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 236 of 470

Hyoscyamine Sulfate Dihydrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-726-2015
Recall number
D-726-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
50 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 237 of 470

Ibuprofen active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-727-2015
Recall number
D-727-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
4000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 238 of 470

Idebenone active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-728-2015
Recall number
D-728-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
3100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 239 of 470

Idoxuridine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-729-2015
Recall number
D-729-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
362 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 240 of 470

Imatinib Mesylate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-730-2015
Recall number
D-730-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1240 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 241 of 470

Imiquimod active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-731-2015
Recall number
D-731-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
998 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 242 of 470

Indocyanine Green active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-732-2015
Recall number
D-732-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
271 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 243 of 470

Indomethacin Sodium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-733-2015
Recall number
D-733-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
2500 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 244 of 470

Irbesartan active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-734-2015
Recall number
D-734-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
50 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 245 of 470

Iron Sucrose or Ferric Hydroxide Sucrose Complex active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-735-2015
Recall number
D-735-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
120500 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 246 of 470

Isoproterenol Hydrochloride active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-736-2015
Recall number
D-736-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
30 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 247 of 470

Isosorbide Dinitrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-737-2015
Recall number
D-737-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 248 of 470

Isoxsuprine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-738-2015
Recall number
D-738-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
19510 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 249 of 470

Itraconazole active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-739-2015
Recall number
D-739-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1850 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 250 of 470

Kanamycin Sulfate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-740-2015
Recall number
D-740-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
34765 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 251 of 470

Ketoconazole active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-741-2015
Recall number
D-741-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
3000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 252 of 470

Ketoprofen active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-742-2015
Recall number
D-742-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
84550 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 253 of 470

Ketorolac Tromethamine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-743-2015
Recall number
D-743-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
2185 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 254 of 470

Ketotifen Fumarate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-744-2015
Recall number
D-744-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 255 of 470

L-Asparaginase active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-745-2015
Recall number
D-745-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1172 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 256 of 470

Labetalol HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-746-2015
Recall number
D-746-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 257 of 470

Lamotrigine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-747-2015
Recall number
D-747-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1250 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 258 of 470

Lansoprazole active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-748-2015
Recall number
D-748-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
3550 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 259 of 470

Lanthanum Carbonate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-749-2015
Recall number
D-749-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
550 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 260 of 470

Leflunomide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-750-2015
Recall number
D-750-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
2865 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 261 of 470

Letrazole active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-751-2015
Recall number
D-751-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 262 of 470

Leucovorin Calcium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-752-2015
Recall number
D-752-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
9611 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 263 of 470

Levalbuterol HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-753-2015
Recall number
D-753-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 264 of 470

Levetiracetam active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-754-2015
Recall number
D-754-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
75311 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 265 of 470

Levocetirizine Dihydrochloride active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-755-2015
Recall number
D-755-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
18245 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 266 of 470

Levocetirizine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-756-2015
Recall number
D-756-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
2500 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 267 of 470

Levodopa or L-Dihydroxyphenylalanine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-757-2015
Recall number
D-757-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1500 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 268 of 470

Levofloxacin Hemihydrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-758-2015
Recall number
D-758-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
25606 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 269 of 470

Levomefolate Calcium or L-5-Methyltetrahydrofolate Calcium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-759-2015
Recall number
D-759-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
696 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 270 of 470

Levosulpiride active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-760-2015
Recall number
D-760-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
14350 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 271 of 470

Levothyroxine Sodium (T4) active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-761-2015
Recall number
D-761-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
4605 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 272 of 470

Lidocaine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-762-2015
Recall number
D-762-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
33300 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 273 of 470

Lincomycin HCl Monohydrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-763-2015
Recall number
D-763-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
8000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 274 of 470

Linezolid active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-764-2015
Recall number
D-764-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 275 of 470

Liothyronine Sodium (T3) active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-765-2015
Recall number
D-765-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
101 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 276 of 470

Lisinopril active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-766-2015
Recall number
D-766-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 277 of 470

Lodenafil Carbonate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-767-2015
Recall number
D-767-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 278 of 470

Lomustine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-768-2015
Recall number
D-768-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
4999 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 279 of 470

Loratadine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-769-2015
Recall number
D-769-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
50 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 280 of 470

Losartan Potassium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-770-2015
Recall number
D-770-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
6525 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 281 of 470

Magnesium Stearate pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-771-2015
Recall number
D-771-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
3000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 282 of 470

Mebendazole active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-772-2015
Recall number
D-772-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
7000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 283 of 470

Mechlorethamine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-773-2015
Recall number
D-773-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
2500 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 284 of 470

Meclofenoxate HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-774-2015
Recall number
D-774-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 285 of 470

Mefloquine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-775-2015
Recall number
D-775-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
50 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 286 of 470

Meloxicam active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-776-2015
Recall number
D-776-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
16666 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 287 of 470

Melphalan active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-777-2015
Recall number
D-777-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
132 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 288 of 470

Memantine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-778-2015
Recall number
D-778-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
40 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 289 of 470

Mepivacaine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-779-2015
Recall number
D-779-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 290 of 470

Metaxalone active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-780-2015
Recall number
D-780-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 291 of 470

Metformin HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-781-2015
Recall number
D-781-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 292 of 470

Methimazole active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-782-2015
Recall number
D-782-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
2000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 293 of 470

Methazolamide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-783-2015
Recall number
D-783-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
25522 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 294 of 470

Methocarbamol active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-784-2015
Recall number
D-784-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
250 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 295 of 470

Methotrexate Sodium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-785-2015
Recall number
D-785-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
25 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 296 of 470

Methotrexate USP active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-786-2015
Recall number
D-786-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
3105 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 297 of 470

Methscopolamine Bromide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-787-2015
Recall number
D-787-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
45 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 298 of 470

Methscopolamine Bromide Combo active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-788-2015
Recall number
D-788-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
10 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 299 of 470

Methyl 5-Aminolevulinate Hydrochloride active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-789-2015
Recall number
D-789-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
120 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 300 of 470

Methyl Folate Calcium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-790-2015
Recall number
D-790-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
5 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 301 of 470

Methylprednisolone Acetate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-791-2015
Recall number
D-791-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
340 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 302 of 470

Methylprednisolone Base active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-792-2015
Recall number
D-792-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
150 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 303 of 470

Metronidazole Base active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-793-2015
Recall number
D-793-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
11000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 304 of 470

Metronidazole Benzoate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-794-2015
Recall number
D-794-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
10000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 305 of 470

Mevastatin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-795-2015
Recall number
D-795-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 306 of 470

Mexiletine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-796-2015
Recall number
D-796-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
24400 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 307 of 470

Miconazole Nitrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-797-2015
Recall number
D-797-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 308 of 470

Miltefosine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-798-2015
Recall number
D-798-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
25 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 309 of 470

Minocycline HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-799-2015
Recall number
D-799-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
12500 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 310 of 470

Minoxidil active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-800-2015
Recall number
D-800-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
4600 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 311 of 470

Mirtazapine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-801-2015
Recall number
D-801-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
4181 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 312 of 470

Misoprostol 1% active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-802-2015
Recall number
D-802-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
27836 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 313 of 470

Mitomycin C active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-803-2015
Recall number
D-803-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
2356 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 314 of 470

Mitotane active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-804-2015
Recall number
D-804-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
21500 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 315 of 470

Mometasone Furoate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-805-2015
Recall number
D-805-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1620 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 316 of 470

Monobenzone active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-806-2015
Recall number
D-806-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
9800 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 317 of 470

Montelukast Sodium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-807-2015
Recall number
D-807-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
150 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 318 of 470

Moxifloxacin HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-808-2015
Recall number
D-808-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1600 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 319 of 470

Mupirocin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-809-2015
Recall number
D-809-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1220 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 320 of 470

Mycophenolate Mofetil active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-810-2015
Recall number
D-810-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
41500 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 321 of 470

Naftifine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-811-2015
Recall number
D-811-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 322 of 470

Naproxen Base active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-812-2015
Recall number
D-812-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 323 of 470

Naproxen Sodium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-813-2015
Recall number
D-813-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1500 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 324 of 470

Natamycin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-814-2015
Recall number
D-814-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
200 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 325 of 470

Neostigmine Methylsulfate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-815-2015
Recall number
D-815-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
302 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 326 of 470

Nevirapine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-816-2015
Recall number
D-816-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 327 of 470

Nilotinib active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-817-2015
Recall number
D-817-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
10 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 328 of 470

Nitazoxanide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-818-2015
Recall number
D-818-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
9550 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 329 of 470

Nitrofurantoin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-819-2015
Recall number
D-819-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
5025 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 330 of 470

Norethindrone Acetate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-820-2015
Recall number
D-820-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
30 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 331 of 470

Ofloxacin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-821-2015
Recall number
D-821-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1600 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 332 of 470

Olsalazine Sodium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-822-2015
Recall number
D-822-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
200 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 333 of 470

Omeprazole active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-823-2015
Recall number
D-823-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
11250 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 334 of 470

Omeprazole Sodium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-824-2015
Recall number
D-824-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
5100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 335 of 470

Ondansetron HCl Dihydrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-825-2015
Recall number
D-825-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
2035 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 336 of 470

Orphenadrine Citrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-826-2015
Recall number
D-826-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
2000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 337 of 470

Oseltamivir Phosphate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-827-2015
Recall number
D-827-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
2915 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 338 of 470

Oxcarbazepine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-828-2015
Recall number
D-828-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
200 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 339 of 470

Paclitaxel Semi-Synthetic active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-829-2015
Recall number
D-829-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
10 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 340 of 470

Pancuronium Bromide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-830-2015
Recall number
D-830-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
20 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 341 of 470

Pantoprazole Sodium Monohydrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-831-2015
Recall number
D-831-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1800 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 342 of 470

Paromomycin Sulphate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-832-2015
Recall number
D-832-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
25 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 343 of 470

Paroxetine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-833-2015
Recall number
D-833-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
500 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 344 of 470

Paroxetine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-834-2015
Recall number
D-834-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
450 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 345 of 470

Penciclovir active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-835-2015
Recall number
D-835-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
25 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 346 of 470

Pentosan Polysulfate Sodium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-836-2015
Recall number
D-836-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
36955 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 347 of 470

Pergolide Mesylate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-837-2015
Recall number
D-837-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1953 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 348 of 470

Pheniramine Maleate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-838-2015
Recall number
D-838-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
10 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 349 of 470

Phenolphthalein active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-839-2015
Recall number
D-839-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
500 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 350 of 470

Phenoxybenzamine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-840-2015
Recall number
D-840-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
9805 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 351 of 470

Phentolamine Mesylate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-841-2015
Recall number
D-841-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
4530 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 352 of 470

Pimecrolimus active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-842-2015
Recall number
D-842-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1200 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 353 of 470

Pioglitazone HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-843-2015
Recall number
D-843-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 354 of 470

Piperacillin Sodium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-844-2015
Recall number
D-844-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
Stability Data Does Not Support Expiry

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Stability Data Does Not Support Expiry: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged without data to support the printed expiry date.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 355 of 470

Piroxicam active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-845-2015
Recall number
D-845-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
2900 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 356 of 470

Podophyllum Resin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-846-2015
Recall number
D-846-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 357 of 470

Polidocanol active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-847-2015
Recall number
D-847-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1200 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 358 of 470

Polidocanol (Industrial Grade) active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-848-2015
Recall number
D-848-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 359 of 470

Potassium Acetate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-849-2015
Recall number
D-849-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
50000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 360 of 470

Potassium Chloride active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-850-2015
Recall number
D-850-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
25000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 361 of 470

Potassium Phosphate Monobasic pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-851-2015
Recall number
D-851-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
3600 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 362 of 470

Povidone K-30 pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-852-2015
Recall number
D-852-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
2100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 363 of 470

Pralidoxime Chloride active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-853-2015
Recall number
D-853-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
3000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 364 of 470

Prazosin HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-854-2015
Recall number
D-854-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
5300 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 365 of 470

Prednisolone Acetate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-855-2015
Recall number
D-855-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
2000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 366 of 470

Prednisolone Anhydrous active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-856-2015
Recall number
D-856-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
31800 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 367 of 470

Prednisolone Anhydrous Micronized active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-857-2015
Recall number
D-857-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
200 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 368 of 470

Prednisone active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-858-2015
Recall number
D-858-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
5000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 369 of 470

Pregabalin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-859-2015
Recall number
D-859-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
2900 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 370 of 470

Pregelatinized Starch pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-860-2015
Recall number
D-860-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
5100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 371 of 470

Prilocaine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-861-2015
Recall number
D-861-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
2100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 372 of 470

Primaquine Phosphate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-862-2015
Recall number
D-862-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1985 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 373 of 470

Procainamide HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-863-2015
Recall number
D-863-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
2700 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 374 of 470

Procaine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-864-2015
Recall number
D-864-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
4575 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 375 of 470

Procaine Penicillin G active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-865-2015
Recall number
D-865-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
Stability Data Does Not Support Expiry

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Stability Data Does Not Support Expiry: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged without data to support the printed expiry date.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 376 of 470

Procarbazine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-866-2015
Recall number
D-866-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
5115 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 377 of 470

Progesterone active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-867-2015
Recall number
D-867-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
2100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 378 of 470

Progesterone Soy Source active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-868-2015
Recall number
D-868-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
5000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 379 of 470

Progesterone Ultra-Micronized active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-869-2015
Recall number
D-869-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
18025 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 380 of 470

Proparacaine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-870-2015
Recall number
D-870-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
200 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 381 of 470

Pyrazinamide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-871-2015
Recall number
D-871-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
5000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 382 of 470

Pyridostigmine Bromide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-872-2015
Recall number
D-872-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1658 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 383 of 470

Quetiapine Fumarate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-873-2015
Recall number
D-873-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1300 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 384 of 470

Quinine Sulfate Dihydrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-874-2015
Recall number
D-874-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
5800 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 385 of 470

Ranitidine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-875-2015
Recall number
D-875-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
5000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 386 of 470

Rebamipide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-876-2015
Recall number
D-876-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
300 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 387 of 470

Reserpine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-877-2015
Recall number
D-877-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
15 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 388 of 470

Retinoic Acid active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-878-2015
Recall number
D-878-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 389 of 470

Ribavirin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-879-2015
Recall number
D-879-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
2000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 390 of 470

Rifaximin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-880-2015
Recall number
D-880-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
13960 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 391 of 470

Ritonavir active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-881-2015
Recall number
D-881-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
30 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 392 of 470

Rivaroxaban active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-882-2015
Recall number
D-882-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
200 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 393 of 470

Rocuronium Bromide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-883-2015
Recall number
D-883-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1550 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 394 of 470

Roflumilast active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-884-2015
Recall number
D-884-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
10 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 395 of 470

Ropivacaine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-885-2015
Recall number
D-885-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
8145 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 396 of 470

Roxithromycin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-886-2015
Recall number
D-886-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 397 of 470

Satraplatin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-887-2015
Recall number
D-887-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
40 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 398 of 470

Secnidazole active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-888-2015
Recall number
D-888-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
12025 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 399 of 470

Secretin Acetate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-889-2015
Recall number
D-889-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1.4 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 400 of 470

Seratonin HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-890-2015
Recall number
D-890-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1454 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 401 of 470

Sertraline HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-891-2015
Recall number
D-891-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1396 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 402 of 470

Sevelamer HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-892-2015
Recall number
D-892-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
500 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 403 of 470

Sildenafil Citrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-893-2015
Recall number
D-893-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
126510 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 404 of 470

Silver Sulfadiazine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-894-2015
Recall number
D-894-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
300 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 405 of 470

Simvastatin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-895-2015
Recall number
D-895-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1610 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 406 of 470

Sirlolimus active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-896-2015
Recall number
D-896-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
157 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 407 of 470

Sodium Dichloroacetate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-897-2015
Recall number
D-897-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 408 of 470

Sodium Gluconate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-898-2015
Recall number
D-898-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
6000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 409 of 470

Sodium Iodide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-899-2015
Recall number
D-899-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
32050 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 410 of 470

Sodium Phenylbutyrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-900-2015
Recall number
D-900-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 411 of 470

Sodium Starch Glycolate pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-901-2015
Recall number
D-901-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
4000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 412 of 470

Sorafenib active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-902-2015
Recall number
D-902-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
5 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 413 of 470

Spectinomycin Sulfate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-903-2015
Recall number
D-903-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
5000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 414 of 470

Streptomycin Sulfate or Sulphate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-904-2015
Recall number
D-904-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
30500 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 415 of 470

Sucralfate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-905-2015
Recall number
D-905-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
15000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 416 of 470

Sulfanilamide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-906-2015
Recall number
D-906-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
33895 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 417 of 470

Sulfathiazole active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-907-2015
Recall number
D-907-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
8500 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 418 of 470

Sulphafurazole (Sulfisoxazole) active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-908-2015
Recall number
D-908-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
4000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 419 of 470

Sumatriptan Succinate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-909-2015
Recall number
D-909-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
7662 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 420 of 470

Tacrolimus Monohydrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-910-2015
Recall number
D-910-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
647 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 421 of 470

Tadalafil active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-911-2015
Recall number
D-911-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
39862 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 422 of 470

Tadalafil Citrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-912-2015
Recall number
D-912-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
3684 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 423 of 470

Tamoxifen Citrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-913-2015
Recall number
D-913-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
500 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 424 of 470

Tamsulosin Base active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-914-2015
Recall number
D-914-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
50 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 425 of 470

Taurolidine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-915-2015
Recall number
D-915-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
300 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 426 of 470

Tegaserod Maleate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-916-2015
Recall number
D-916-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1045 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 427 of 470

Telaprevir active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-917-2015
Recall number
D-917-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
5 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 428 of 470

Temozolomide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-918-2015
Recall number
D-918-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
975 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 429 of 470

Terbinafine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-919-2015
Recall number
D-919-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 430 of 470

Terbinafine Base active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-920-2015
Recall number
D-920-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
5848 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 431 of 470

Terbinafine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-921-2015
Recall number
D-921-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
12600 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 432 of 470

Tetracaine (free base) active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-922-2015
Recall number
D-922-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
15627 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 433 of 470

Tetracaine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-923-2015
Recall number
D-923-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1400 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 434 of 470

Tetracycline HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-924-2015
Recall number
D-924-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
100825 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 435 of 470

Theophylline Anhydrous active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-925-2015
Recall number
D-925-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
3000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 436 of 470

Thimerosal active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-926-2015
Recall number
D-926-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1010 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 437 of 470

Thiotepa active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-927-2015
Recall number
D-927-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
20 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 438 of 470

Thyroid Porcine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-928-2015
Recall number
D-928-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
10000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 439 of 470

Ticarcillin Sodium/Potassium Clavulanate (30:1) active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-929-2015
Recall number
D-929-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
6000 grams

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
Stability Data Does Not Support Expiry

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Stability Data Does Not Support Expiry: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged without data to support the printed expiry date.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 440 of 470

Tiopronin Base active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-930-2015
Recall number
D-930-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1025 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 441 of 470

Tizanidine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-931-2015
Recall number
D-931-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
700 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 442 of 470

Tobramycin Base active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-932-2015
Recall number
D-932-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
3050 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 443 of 470

Tobramycin Sulfate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-933-2015
Recall number
D-933-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 444 of 470

Tolfenamic Acid active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-934-2015
Recall number
D-934-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 445 of 470

Tolvaptan active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-935-2015
Recall number
D-935-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
50 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 446 of 470

Topiramate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-936-2015
Recall number
D-936-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
4150 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 447 of 470

Tramadol HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-937-2015
Recall number
D-937-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
116900 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 448 of 470

Tranexamic Acid active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-938-2015
Recall number
D-938-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
20000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 449 of 470

Tranilast active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-939-2015
Recall number
D-939-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
605 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 450 of 470

Trazodone HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-940-2015
Recall number
D-940-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
500 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 451 of 470

Trehalose Dihydrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-941-2015
Recall number
D-941-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 452 of 470

Tretinoin or All-Trans Retinoic Acid active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-942-2015
Recall number
D-942-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1300 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 453 of 470

Trichlormethiazide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-943-2015
Recall number
D-943-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
3500 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 454 of 470

Trifluridine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-944-2015
Recall number
D-944-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
68 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 455 of 470

Trimeprazine Tartrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-945-2015
Recall number
D-945-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
6778 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 456 of 470

Uridine-5'Triphosphate Trisodium Salt active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-946-2015
Recall number
D-946-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
2000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 457 of 470

Ursodiol active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-947-2015
Recall number
D-947-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
14226 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 458 of 470

Valacyclovir HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-948-2015
Recall number
D-948-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
3050 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 459 of 470

Vancomycin HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-949-2015
Recall number
D-949-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
12875 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 460 of 470

Vardenafil HCl Trihydrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-950-2015
Recall number
D-950-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
16775 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 461 of 470

Vecuronium Bromide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-951-2015
Recall number
D-951-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
50 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 462 of 470

Venlafaxine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-952-2015
Recall number
D-952-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
50 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 463 of 470

Vidarbine Monophosphate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-953-2015
Recall number
D-953-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
50 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 464 of 470

Vincristine Sulfate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-954-2015
Recall number
D-954-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
5 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 465 of 470

Voriconazole active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-955-2015
Recall number
D-955-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1998 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 466 of 470

Zidovudine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-956-2015
Recall number
D-956-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1050 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 467 of 470

Zinc Pyrithione active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-957-2015
Recall number
D-957-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
100 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 468 of 470

Zoledronic Acid active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-958-2015
Recall number
D-958-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
1000 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 469 of 470

Zolmitriptan active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-959-2015
Recall number
D-959-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
2200 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.

drug · product 470 of 470

Zonisamide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

D-960-2015
Recall number
D-960-2015
Initiated
November 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Attix Pharmaceuticals
Quantity
74641 grams

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
cross contamination with penicillin

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Code information

All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution pattern

Nationwide to compounding pharmacies and research organizations.